Hepatic steatosis, characterized by the accumulation of triacylglycerol in hepatocytes, complicates liver transplantation by increasing the risk of ischemia-reperfusion injury (IRI), leading to suboptimal graft outcomes. This condition has become a major cause of liver graft discarding, exacerbating the ongoing organ shortage for transplantation. Recent advances in ex vivo normothermic perfusion machines (NMPs) have provided promising solutions for reconditioning and preserving steatotic liver. NMP supports cellular metabolism and mitigates IRI by maintaining the physiological conditions. In addition, pharmacological strategies to reduce hepatic steatosis have been explored to increase graft viability. In this review, we summarize current insights into hepatic lipid metabolism and the molecular mechanisms underlying steatosis, while discussing emerging pharmacological defatting approaches. These interventions have the potential to address the challenges posed by hepatic steatosis, improve graft quality, expand the availability of transplantable livers, and enhance clinical outcomes of transplant candidates. Finally, we highlight current limitations and outline directions for future research and clinical applications.
Lung transplantation (LTx) is a vital treatment for advanced lung disease. However, in-hospital mortality remains a significant challenge. Identifying perioperative risk factors is crucial for improving outcomes. This study aimed to develop a predictive nomogram for in-hospital mortality in lung transplant recipients. We retrospectively analyzed 1355 LTx recipients at Wuxi People's Hospital (2015-2024). Least absolute shrinkage and selection operator (LASSO) regression identified predictors of in-hospital mortality. A nomogram was constructed and validated using calibration curves, decision curve analysis, and receiver operating characteristic (ROC) curves. The overall in-hospital mortality rate was 14.5 %, with deaths occurring within 20 days post-surgery. Independent predictors included age, ICU stay duration, cold ischemia time, blood transfusion, C-reactive protein, serum sodium, primary graft dysfunction, renal replacement therapy, and extracorporeal membrane oxygenation support. The nomogram showed superior predictive accuracy (AUROC: 0.874, 95 % CI 0.843-0.905) compared to SOFA (AUROC: 0.772, 95 % CI 0.732-0.812) and APACHE II scores (AUROC: 0.718, 95 % CI 0.673-0.764). Calibration and decision curve analyses confirmed its accuracy and clinical utility. This study highlights key perioperative risk factors for in-hospital mortality in LTx recipients. The developed nomogram provides a reliable tool for predicting early mortality, aiding clinicians in optimizing patient management.